November 3, 2016 / 11:47 AM / in a year

BRIEF-Immunovaccine provides update on preclinical study

Nov 3 (Reuters) - Immunovaccine Inc

* Neoepitope peptides formulated in immunovaccine’s depovax(tm) vaccine platform show significant positive results in preclinical studies Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below